More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system. (Q38191755)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

review article

1 reference

title

More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Matteo Caleo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Riccardo Mazzocchio

series ordinal

1

1 reference

30 August 2017

Matteo Caleo

series ordinal

2

1 reference

30 August 2017

language of work or name

1 reference

26 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

44-61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24576870%20AND%20SRC:MED&resulttype=core&format=json

Transsynaptic inhibition of spinal transmission by A2 botulinum toxin.

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

The influence of merged muscle excitation modules on post-stroke hemiparetic walking performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Intrahippocampal infusion of botulinum neurotoxin E (BoNT/E) reduces spontaneous recurrent seizures in a mouse model of mesial temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Acute neuroprotection by the synaptic blocker botulinum neurotoxin E in a rat model of focal cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

OnabotulinumtoxinA for the treatment of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Spinal plasticity in stroke patients after botulinum neurotoxin A injection in ankle plantar flexors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum toxin type A reduces pain supersensitivity in experimental diabetic neuropathy: bilateral effect after unilateral injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum neurotoxin type D enables cytosolic delivery of enzymatically active cargo proteins to neurones via unfolded translocation intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Networks of inhibitory and excitatory commissural interneurons mediating crossed reticulospinal actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Central neuron-glia interactions and neuropathic pain: overview of recent concepts and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Cell entry strategy of clostridial neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

A reappraisal of the central effects of botulinum neurotoxin type A: by what mechanism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Transient synaptic silencing of developing striate cortex has persistent effects on visual function and plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

The role of activity in synaptic degeneration in a protein misfolding disease, prion disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Central effects of tetanus and botulinum neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Sympathetic block with botulinum toxin to treat complex regional pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Retargeted clostridial endopeptidases: inhibition of nociceptive neurotransmitter release in vitro, and antinociceptive activity in in vivo models of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Merging of healthy motor modules predicts reduced locomotor performance and muscle coordination complexity post-stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

The effects of botulinum neurotoxin A induced muscle paresis during a critical period upon muscle and spinal cord development in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Appearance of reciprocal facilitation of ankle extensors from ankle flexors in patients with stroke or spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Spinal cord pattern generators for locomotion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

SV2 is the protein receptor for botulinum neurotoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Transmission in heteronymous spinal pathways is modified after stroke and related to motor incoordination

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Different time courses of recovery after poisoning with botulinum neurotoxin serotypes A and E in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Different antinociceptive effects of botulinum toxin type A in inflammatory and peripheral polyneuropathic rat models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Synthetic self-assembling clostridial chimera for modulation of sensory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Regulation of gephyrin cluster size and inhibitory synaptic currents on Renshaw cells by motor axon excitatory inputs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Effects of type a botulinum toxin on the cholinergic transmission at spinal renshaw cells and on the inhibitory action at ia inhibitory interneurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Neurotransmission selectively regulates synapse formation in parallel circuits in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

The H-reflex as a probe: pathways and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Reduced reciprocal inhibition during assisted stepping in human spinal cord injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Beyond muscular effects: depression of spinal recurrent inhibition after botulinum neurotoxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

The analgesic effect on neuropathic pain of retrogradely transported botulinum neurotoxin A involves Schwann cells and astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Facilitation of transmission in heteronymous group II pathways in spastic hemiplegic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Engineered botulinum neurotoxins as new therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Organization of mammalian locomotor rhythm and pattern generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum neurotoxin: a marvel of protein design

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Modular control of human walking: a simulation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum neurotoxin subtype A2 enters neuronal cells faster than subtype A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Evidence for anterograde transport and transcytosis of botulinum neurotoxin A (BoNT/A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum neurotoxin A impairs neurotransmission following retrograde transynaptic transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Synaptic targeting of retrogradely transported trophic factors in motoneurons: comparison of glial cell line-derived neurotrophic factor, brain-derived neurotrophic factor, and cardiotrophin-1 with tetanus toxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Presumptive Renshaw cells contain decreased calbindin during recovery from sciatic nerve lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Synaptic activation of facial afferents on the facial neurons of the cat

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum toxin and intractable trigeminal neuralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum neurotoxin A enhances the analgesic effects on inflammatory pain and antagonizes tolerance induced by morphine in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Traffic of botulinum toxins A and E in excitatory and inhibitory neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

A dileucine in the protease of botulinum toxin A underlies its long-lived neuroparalysis: transfer of longevity to a novel potential therapeutic

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Novel chimeras of botulinum and tetanus neurotoxins yield insights into their distinct sites of neuroparalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Characterization of botulinum neurotoxin A subtypes 1 through 5 by investigation of activities in mice, in neuronal cell cultures, and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

On the role of recurrent inhibitory feedback in motor control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Intrastriatal botulinum toxin abolishes pathologic rotational behaviour and induces axonal varicosities in the 6-OHDA rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633

Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1073858414524633